MedPath

Vancomycin hydrochloride

These highlights do not include all the information needed to use VANCOMYCIN HYDROCHLORIDE FOR INJECTION safely and effectively. See full prescribing information for VANCOMYCIN HYDROCHLORIDE FOR INJECTION. VANCOMYCIN HYDROCHLORIDE for injection, for intravenous use Initial U.S. Approval: 1958

Approved
Approval ID

9aa42538-c84e-4886-8d3d-a7dfded5120f

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 5, 2023

Manufacturers
FDA

Eugia US LLC

DUNS: 968961354

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Vancomycin hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code55150-471
Application NumberANDA217401
Product Classification
M
Marketing Category
C73584
G
Generic Name
Vancomycin hydrochloride
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateAugust 5, 2023
FDA Product Classification

INGREDIENTS (1)

VANCOMYCIN HYDROCHLORIDEActive
Quantity: 1.25 g in 25 mL
Code: 71WO621TJD
Classification: ACTIM

Vancomycin hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code55150-472
Application NumberANDA217401
Product Classification
M
Marketing Category
C73584
G
Generic Name
Vancomycin hydrochloride
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateAugust 5, 2023
FDA Product Classification

INGREDIENTS (1)

VANCOMYCIN HYDROCHLORIDEActive
Quantity: 1.5 g in 30 mL
Code: 71WO621TJD
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Vancomycin hydrochloride - FDA Drug Approval Details